Blogs

Blogs

ASCOconnection.org is a forum for the exchange of views on topical issues in the field of oncology. The views expressed in the blogs, comments, and forums belong to the authors. They do not necessarily reflect the views or positions of the American Society of Clinical Oncology. Please read the Commenting Guidelines.

No Results.

Dr. Jennifer Temel and Dr. Daniel E. Lage discuss building a career in cancer symptom management research.
If luck, as Louis Pasteur noted, favors the prepared mind, how will oncologists not only prepare but extend cognitive capacity in an era where both medical knowledge and the scope of human endeavor that physicians must address continue to increase exponentially?
Despite limitations, some winds of change are noticeable regarding clinical research in the Latin America and Caribbean region, according to Dr. Matías Chacón, Dr. Diego Enrico, and Dr. Federico Waisberg.
"It is my hope that 10 years from now we will look back on this time—one in which the pandemic laid bare glaring inequities in health care—as an inflection point," said Michael Burton.
"2020 will be a year we at CancerLinQ look back on with mixed emotion because, in the midst of the pandemic, we achieved a momentous milestone," said Dr. Danielle Potter.
Every day in clinic, Dr. Narjust Duma is reminded of the importance of sexual health in cancer care. 
I interviewed Dr. Lawrence with the hope that others will be inspired by his groundbreaking work in international trial design.
Peer review, writes Dr. Yara Abdou, is not a task, but a privilege, and an invaluable experience for the reviewer to enhance their critical thinking and engage in an invigorating academic community.
A spirit of clinically relevant discovery and accessible, understandable knowledge dissemination is the profound legacy, responsibility, and obligation that Rich will leave at ASCO, and we will honor him by continuing this work at the level of rigor and quality he established.
By holding its scientific program on time, ASCO and the entire oncology community make a pledge that we will continue advancing and offering the best care for our patients worldwide. 
We have an urgent need to learn more about how COVID-19 is directly and indirectly affecting the people with cancer whom we serve.
The number of new and old agents being suggested as COVID-19 therapies seems to be expanding exponentially. Dr. Donald L. Trump, Dr. Courtney W. Houchen, and Dr. Milton L. Brown highlight current investigations.
The TMPRSS2 protein has a role in both COVID-19 and in prostate cancer, suggesting intriguing avenues of inquiry for researchers engaged in the fight against COVID-19.
My coauthors and I call on every oncology caregiver and stakeholder to join us in the fight against our lack of information and help us gather the data that will be paramount to guide our practices in this new reality.
ASCO's chief medical officer Dr. Richard L. Schilsky and I discuss the refinement of cancer surgery, the critical importance of federally funded research, and ASCO's research priorities for the oncology community.
Let’s look critically at the prospective trial evaluating the association of ringing a bell with distress experienced by patients with cancer.
As we begin our work in 2020, I am excited that we are building on the remarkable successes of 2019, and the years before, with growing collaboration and sharpening focus. 
As we celebrate the 20th anniversary of World Cancer Day this February 4, it’s important to recognize that we are making progress in addressing cancer.

Pages


Advertisement